The present study was an observational, multicenter, non-interventional, single arm, open label, PMS study conducted in Iran.~Data was gathered in two booklets, each containing information on four cycles of chemotherapy, which was filled by the designated physician. The duration of PegaGen® treatment was at the physicians' discretion based on the patient's condition.~The primary objective of this study was safety assessment, including the rate of AEs. The secondary objective was the effectiveness evaluation in the prevention of chemotherapy-induced FN.~This study was single arm and 654 subjects participated across various tumor types and regimens.
The present study was an observational, multicenter, non-interventional, single arm, open label, PMS study conducted in Iran.~The primary objective of this study was safety assessment, including the rate of AEs. The secondary objective was the effectiveness evaluation in the prevention of chemotherapy-induced FN.